← SynDRA
Cur-61414
SynDRA canonical compound SYN0469091 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | DHH | IHH | PTCH1 | SMO |
|---|
| Mechanism of action | smoothened receptor antagonist |
|---|
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- COMT
- CP2C9
- CP3A7
- GAMT
- GNMT
- HNMT
- NNMT
- NR1I3
- PNMT
Cross-references
Synonyms
- CUR61414
- G-024856
- RefChem:128850
- Smoothened Antagonist CUR-61414
- G-856
- UNII-809U4O7OQO
- orb1707418
- SCHEMBL8256419
- SCHEMBL29373119
- C31H42N4O5
- GLXC-15972
- BDBM50249519
- EX-A10643
- MFCD20275055
- AKOS030242346
- FB20593
- DA-72427
- MS-30081
- HY-113965
- CS-0064795
- G14092
- T15019
- G-024586
- BRD-K69624312-001-01-1
- N-[(3S,5S)-1-(1,3-benzodioxol-5-ylmethyl)-5-(piperazine-1-carbonyl)pyrrolidin-3-yl]-N-[(3-methoxyphenyl)methyl]-3,3-dimethylbutanamide
Look up Cur-61414 in the interactive SynDRA portal →